Objective: Total hip arthroplasty (THA) effectively treats end-stage hemophilic hip arthropathy. Given hemophilia’s unique characteristics, perioperative bleeding remains a significant risk for patients undergoing THA. Tranexamic acid (TXA), an efficient antifibrinolytic agent, may benefit the outcomes of THA for patients with hemophilia (PWH). This study aims to explore the clinical efficacy of intra-articular injection of TXA in treating perioperative bleeding in PWH and assess its additional clinical benefits.
Methods: The retrospective study comprised data of PWH who received THA from January 2015 to December 2021 in the research center. A total of 59 individuals were included in the study, divided into a TXA group (n = 31) and a non-TXA group (n = 28). We compared various parameters, including total blood loss (TBL), visible blood loss (VBL), occult blood loss (OBL), intraoperative coagulation factor VIII (FVIII) consumption, perioperative total FVIII consumption, hemoglobin (HB), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), length of hospital stay, hospitalization costs, length of surgery, total protein, activated partial thromboplastin time (APTT), D-dimer, rate of joint swelling, hip joint range of motion (ROM), visual analogue scale (VAS), and Harris hip joint function scale (HHS) between the two groups. Follow-up assessments were conducted for up to 24 months. A Student’s t test was utilized for the statistical analysis.
Results: This study demonstrated that intra-articular TXA effectively reduced TBL (1248.19 ± 439.88 mL, p < 0.001), VBL (490.32 ± 344.34 mL, p = 0.003), and OBL (757.87 ± 381.48 mL, p = 0.004) in PWH who underwent THA. TXA demonstrated effectiveness in reducing VAS scores on POD1, POD7, and POD14 and joint swelling rates on POD1, POD7, POD14, and at discharge (p < 0.05). Additionally, the TXA group achieved higher HHS ratings at all follow-up time points (p < 0.05), showing superior hip joint mobility, lower postoperative inflammation levels, reduced factor VIII consumption during surgery, and less postoperative nutritional loss. No statistically significant differences were observed between the two groups in terms of hospital stay, hospitalization costs, surgery duration, and coagulation indicators.
Conclusion: Intra-articular injection of TXA reduces perioperative bleeding in PWH undergoing THA while also improving joint mobility, post-operative rehabilitation, and quality of life. This may provide value for the future application of TXA in PWH.
| [1] |
Berntorp E, Fischer K, Hart DP, Mancuso ME, Stephensen D, Shapiro AD, et al. Haemophilia. Nat Rev Dis Primers. 2021; 7(1): 45.
|
| [2] |
Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments, and its complications. Lancet. 2016; 388(10040): 187–197.
|
| [3] |
Gualtierotti R, Solimeno LP, Peyvandi F. Hemophilic arthropathy: current knowledge and future perspectives. J Thromb Haemost. 2021; 19(9): 2112–2121.
|
| [4] |
Gillinov SM, Burroughs PJ, Moore HG, Rubin LE, Frumberg DB, Grauer JN. Total hip arthroplasty in patients with classic hemophilia: a matched comparison of 90-day outcomes and 5-year implant survival. J Arthroplasty. 2022; 37(7): 1333–1337.
|
| [5] |
Rodriguez-Merchan EC. Serological biomarkers in hemophilic arthropathy: can they be used to monitor bleeding and ongoing progression of blood-induced joint disease in patients with hemophilia? Blood Rev. 2020; 41: 100642.
|
| [6] |
Verhagen MJA, van Balen EC, Blijlevens NMA, Coppens M, van Heerde WL, Leebeek FWG, et al. Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease. J Thromb Haemost. 2024; 22(1): 152–162.
|
| [7] |
Rehill AM, McCluskey S, O’Donnell JS, Dockal M, Preston RJS. Heterogeneity in bleeding tendency and arthropathy development in individuals with hemophilia. Semin Thromb Hemost. 2021; 47(2): 183–191.
|
| [8] |
Gong Y, Su H, Jin Z, Zhou H, Chen L, Chen R, et al. Bleeder’s femur: the proximal femoral morphology in hemophilic patients who underwent Total hip arthroplasty. Orthop Surg. 2024; 16(3): 718–723.
|
| [9] |
Kleiboer B, Layer MA, Cafuir LA, Cuker A, Escobar M, Eyster ME, et al. Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: a prospective multicenter observational study. J Thromb Haemost. 2022; 20(4): 857–865.
|
| [10] |
Mensah PK, Pavord S. Managing preoperative hemostasis in patients with inherited and acquired bleeding disorders. Semin Thromb Hemost. 2020; 46(1): 17–25.
|
| [11] |
DeFrancesco CJ, Reichel JF, Gbaje E, Popovic M, Freeman C, Wong M, et al. Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: a randomised, non-inferiority trial. Br J Anaesth. 2023; 130(2): 234–241.
|
| [12] |
Levack AE, McLawhorn AS, Dodwell E, DelPizzo K, Nguyen J, Sink E. Intravenous tranexamic acid reduces blood loss and transfusion requirements after periacetabular osteotomy. 2020; 102-B(9): 1151–1157.
|
| [13] |
Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg. 2013; 100(10): 1271–1279.
|
| [14] |
Ker K, Beecher D, Roberts I. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev. 2013;(7): CD010562.
|
| [15] |
Xiang SC, Shen SN, Wang R, Wang ZM, Jin ZK, Su H, et al. Intra-articular injection of tranexamic acid in patients with haemophilia arthritis: retrospective controlled study in total knee arthroplasty. Int Orthop. 2023; 48: 683–692.
|
| [16] |
Shen SN, Wu DX, Lv SJ, Tong PJ. Hidden blood loss of total knee arthroplasty in hemophilia arthritis: an analysis of influencing factors. BMC Musculoskelet Disord. 2022; 23(1): 587.
|
| [17] |
Shah A, Palmer AJR, Klein AA. Strategies to minimize intraoperative blood loss during major surgery. Br J Surg. 2020; 107(2): e26–e38.
|
| [18] |
Karl V, Thorn S, Mathes T, Hess S, Maegele M. Association of tranexamic acid administration with mortality and thromboembolic events in patients with traumatic injury: a systematic review and meta-analysis. JAMA Netw Open. 2022; 5(3): e220625.
|
| [19] |
Muthu S, Ramakrishnan E, Natarajan KK, Chellamuthu G. Risk-benefit analysis of wound drain usage in spine surgery: a systematic review and meta-analysis with evidence summary. Eur Spine J. 2020; 29(9): 2111–2128.
|
| [20] |
Hunt BJ. The current place of tranexamic acid in the management of bleeding. Anaesthesia. 2015; 70(Suppl 1): 50–53-e18.
|
| [21] |
Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care. 2007; 11(6): R117.
|
| [22] |
Jimenez JJ, Iribarren JL, Brouard M, Hernandez D, Palmero S, Jimenez A, et al. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg. 2011; 6: 138.
|
| [23] |
Okholm SH, Krog J, Hvas AM. Tranexamic acid and its potential anti-inflammatory effect: a systematic review. Semin Thromb Hemost. 2022; 48(5): 568–595.
|
| [24] |
Di Napoli M, Parry-Jones AR, Smith CJ, Hopkins SJ, Slevin M, Masotti L, et al. C-reactive protein predicts hematoma growth in intracerebral hemorrhage. Stroke. 2014; 45(1): 59–65.
|
| [25] |
Myles PS, Richards T, Klein A, Wood EM, Wallace S, Shulman MA, et al. Postoperative anaemia and patient-centred outcomes after major abdominal surgery: a retrospective cohort study. Br J Anaesth. 2022; 129(3): 346–354.
|
| [26] |
Hirsch KR, Wolfe RR, Ferrando AA. Pre-and post-surgical nutrition for preservation of muscle mass, strength, and functionality following orthopedic surgery. Nutrients. 2021; 13(5): 1675.
|
| [27] |
Panzenbeck P, von Keudell A, Joshi GP, Xu CX, Vlassakov K, Schreiber KL, et al. Procedure-specific acute pain trajectory after elective total hip arthroplasty: systematic review and data synthesis. Br J Anaesth. 2021; 127(1): 110–132.
|
| [28] |
Li JW, Ma YS, Xiao LK. Postoperative pain management in total knee arthroplasty. Orthop Surg. 2019; 11(5): 755–761.
|
| [29] |
Bahl JS, Nelson MJ, Taylor M, Solomon LB, Arnold JB, Thewlis D. Biomechanical changes and recovery of gait function after total hip arthroplasty for osteoarthritis: a systematic review and meta-analysis. Osteoarthr Cartil. 2018; 26(7): 847–863.
|
| [30] |
Hermans C, Hammer F, Lobet S, Lambert C. Subclinical deep venous thrombosis observed in 10% of hemophilic patients undergoing major orthopedic surgery. J Thromb Haemost. 2010; 8(5): 1138–1140.
|
| [31] |
Martin K, Key NS. How I treat patients with inherited bleeding disorders who need anticoagulant therapy. Blood. 2016; 128(2): 178–184.
|
| [32] |
Pagliari MT, Boscarino M, Cairo A, Mancini I, Martinelli I, Bucciarelli P, et al. ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis. Thromb Res. 2021; 197: 132–137.
|
| [33] |
Sander M, Spies CD, Martiny V, Rosenthal C, Wernecke KD, von Heymann C. Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis. Crit Care. 2010; 14(4): R148.
|
| [34] |
Wang SH, Chung CH, Chen YC, Cooper AM, Chien WC, Pan RY. Does hemophilia increase risk of adverse outcomes following total hip and knee arthroplasty? A propensity score-matched analysis of a nationwide, population-based study. J Arthroplasty. 2019; 34(10): 2329–2336.e1.
|
| [35] |
Chavez MA, Bogert JN, Soe-Lin H, Jacobs JV, Chapple KM, Weinberg JA. Length of stay and trauma center finances: a disparity of payer source at a level I trauma center. J Trauma Acute Care Surg. 2022; 92(4): 683–690.
|
| [36] |
Wohlgemut JM, Ramsay G, Boyers D, Jansen JO. Current and projected financial burden of emergency general surgery for adults in Scotland’s single payer healthcare system: a cost analysis of hospital admissions. Ann Surg. 2021; 274(6): e522–e528.
|
RIGHTS & PERMISSIONS
2024 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
PDF
